​
​

Nexalin (NXL) Revenue & Revenue Breakdown

OverviewOwnershipFinancialsChart

Nexalin Revenue Highlights

Latest Revenue (Y)

$110.75K

Latest Revenue (Q)

$36.03K

Main Segment (Y)

Licensing Fee

Main Geography (Y)

UNITED STATES

Nexalin Revenue by Period

Nexalin Revenue by Year

DateRevenueChange
2023-12-31--91.62%
2022-12-31-817.20%
2021-12-31--40.69%
2020-12-31-17.13%
2019-12-31--

Nexalin generated $110.75K in revenue during NA 2023, up -91.62% compared to the previous quarter, and up 0.00% compared to the same period a year ago.

Nexalin Revenue by Quarter

DateRevenueChange
2024-09-30-34.24%
2024-06-30--65.88%
2024-03-31-283.09%
2023-12-31--14.83%
2023-09-30--32.15%
2023-06-30-16.30%
2023-03-31--20.47%
2022-12-31--92.95%
2022-09-30-31.63%
2022-06-30-28.13%
2022-03-31-1247.23%
2021-12-31--57.12%
2021-09-30-91.99%
2021-06-30--16.57%
2021-03-31-7.51%
2020-12-31--11.93%
2020-09-30--57.46%
2020-06-30--
2020-03-31--

Nexalin generated $36.03K in revenue during Q3 2024, up 34.24% compared to the previous quarter, and up 101.38% compared to the same period a year ago.

Nexalin Revenue Breakdown

Nexalin Revenue Breakdown by Product

Annual Revenue by Product

Product/ServiceDec 23Dec 22
Other--
Licensing Fee--
Equipment--
Device Sales--

Nexalin's latest annual revenue breakdown by segment (product or service), as of Dec 23: Licensing Fee (74.11%), Equipment (24.65%), and Other (1.24%).

Quarterly Revenue by Product

Product/ServiceSep 24Mar 24Dec 23Sep 23Jun 23Mar 23Dec 22Sep 22
Equipment--------
Other--------
Licensing Fee--------
Device Sales--------

Nexalin's latest quarterly revenue breakdown by segment (product or service), as of Sep 24: Equipment (52.18%), Licensing Fee (47.02%), and Other (0.80%).

Nexalin Revenue Breakdown by Country

Annual Revenue by Country

CountryDec 23Dec 22
UNITED STATES--
CHINA--

Nexalin's latest annual revenue breakdown by geography, as of Dec 23: UNITED STATES (96.74%), and CHINA (3.26%).

Quarterly Revenue by Country

CountrySep 24Mar 24Dec 23Sep 23Jun 23Mar 23Dec 22Sep 22
UNITED STATES--------
CHINA--------

Nexalin's latest quarterly revenue breakdown by geography, as of Sep 24: UNITED STATES (100.00%).

Nexalin Peer Comparison by Revenue

TickerCompanyLast Year RevenueLast Quarter Revenue
LIVNLivaNova--
KIDSOrthoPediatrics--
SRDXSurmodics--
NPCENeuroPace--
IRIXIRIDEX--
AZYOElutia--
LNSRLENSAR--
SSKNSTRATA Skin Sciences--
OSAProSomnus--
INVOINVO Bioscience--
MOTSMotus GI--
AIMDAinos--
NXLNexalin--
BJDXBluejay Diagnostics--
MODDModular Medical--

NXL Revenue FAQ

What is Nexalin’s yearly revenue?

Nexalin's yearly revenue for 2023 was $110.75K, representing a decrease of -91.62% compared to 2022. The company's yearly revenue for 2022 was $1.32M, representing an increase of 817.20% compared to 2021. NXL's yearly revenue for 2021 was $144.06K, representing a decrease of -40.69% compared to 2020.

What is Nexalin’s quarterly revenue?

Nexalin's quarterly revenue for Q3 2024 was $36.03K, a 34.24% increase from the previous quarter (Q2 2024), and a 49.43% increase year-over-year (Q3 2023). The company's quarterly revenue for Q2 2024 was $26.84K, a -65.88% decrease from the previous quarter (Q1 2024), and a -24.48% decrease year-over-year (Q2 2023). NXL's quarterly revenue for Q1 2024 was $78.67K, a 283.09% increase from the previous quarter (Q4 2023), and a 157.43% increase year-over-year (Q1 2023).

What is Nexalin’s revenue growth rate?

Nexalin's revenue growth rate for the last 3 years (2021-2023) was -23.13%, and for the last 5 years (2019-2023) was -46.60%.

What are Nexalin’s revenue streams?

Nexalin's revenue streams in c 23 are Other, Licensing Fee, and Equipment. Other generated $1.37K in revenue, accounting 1.24% of the company's total revenue, down -94.82% year-over-year. Licensing Fee generated $82.08K in revenue, accounting 74.11% of the company's total revenue, up 3.65% year-over-year. Equipment generated $27.3K in revenue, accounting 24.65% of the company's total revenue, up 1.95% year-over-year.

What is Nexalin’s main source of revenue?

For the fiscal year ending Dec 23, the largest source of revenue of Nexalin was Licensing Fee. This segment made a revenue of $82.08K, representing 74.11% of the company's total revenue.